Eye imaging test for premature babies at risk of ROP
Part of Eyes & vision, Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 24 and 34 weeks of pregnancy
- Your baby weighed less than 1500 grams (3.3 pounds) at birth
- Your baby has not had surgery for ROP
- Your baby does not have a serious health issue that would make imaging unsafe, as decided by the care team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study looks at children who had ROP (an eye problem in premature babies) to see how their vision and the back of the eye (retina) develop over time. It compares children who received treatment with those who did not, to learn more about long-term effects.
This study tests a new educational program to help parents of premature babies understand the eye condition ROP (retinopathy of prematurity) and why screening is important. By taking part, you'll learn how to care for your baby's eye health and potentially prevent vision problems.
This study looks at the long-term eye health of people who were born prematurely and screened for a condition called retinopathy of prematurity (ROP), which affects the blood vessels in the eye. It aims to understand how their vision has developed over time.
This study tests two drug-free methods to help reduce pain when premature babies get a special eye exam for retinopathy of prematurity. It may help your baby feel more comfortable during the procedure.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.